<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"><channel rdf:about="https://www.bibsonomy.org/user/avivagabriel/development"><title>BibSonomy bookmarks for /user/avivagabriel/development</title><link>https://www.bibsonomy.org/user/avivagabriel/development</link><description>BibSonomy RSS Feed for /user/avivagabriel/development</description><items><rdf:Seq><rdf:li rdf:resource="http://circ.ahajournals.org/cgi/content/full/109/10/1196"/><rdf:li rdf:resource="http://findarticles.com/p/articles/mi_m1200/is_1_168/ai_n14842196/print"/><rdf:li rdf:resource="http://www.ciaomed.org/articles.cfm?articleID=543"/><rdf:li rdf:resource="http://www.altavista.com/web/results?itag=ody&amp;kgs=0&amp;kls=0&amp;q=atherosclerosis+p38+mitogen-activated+kinase+glaxo&amp;stq=10"/><rdf:li rdf:resource="http://www.jimmunol.org/cgi/content/abstract/168/8/4070"/><rdf:li rdf:resource="http://jpet.aspetjournals.org/cgi/reprint/301/1/15.pdf"/><rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/74585.php"/><rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/75745.php"/><rdf:li rdf:resource="http://www.pharmaceutical-business-review.com/article_news.asp?guid=9A904653-FD9B-44B6-9699-AEBDDC782C1A"/><rdf:li rdf:resource="https://www.cmrinteract.com/clintrial/"/><rdf:li rdf:resource="http://newmeds.phrma.org/"/><rdf:li rdf:resource="http://www.clinicaltrials.jp/user/cte_main.jsp"/><rdf:li rdf:resource="http://www.physorg.com/news102225930.html"/><rdf:li rdf:resource="http://www.km4dev.org/journal/index.php/km4dj"/><rdf:li rdf:resource="http://www.davecheong.com/2007/06/15/waking-up-early-15-tips-that-work/"/><rdf:li rdf:resource="http://www.thepassiontest.com/Passion/home/index.cfm?"/><rdf:li rdf:resource="http://www.tutorialdash.com/"/><rdf:li rdf:resource="http://www.sasklearning.gov.sk.ca/branches/institutions/rpl/docs/Level_1_RPL_Guide.pdf"/><rdf:li rdf:resource="http://www.xml.com/"/><rdf:li rdf:resource="http://www.anecdote.com.au/archives/sensemaking/"/></rdf:Seq></items></channel><item rdf:about="http://circ.ahajournals.org/cgi/content/full/109/10/1196"><title> Inhibitors of Protein Kinase Signaling Pathways: Emerging Therapies for Cardiovascular Disease -- Force et al. 109 (10): 1196 -- Circulation</title><description></description><link>http://circ.ahajournals.org/cgi/content/full/109/10/1196</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-08-07T13:15:59+02:00</dc:date><dc:subject>biomolecular chemokines chronic cytokines development drugs inflammation inflammatory inhibitors interleukins kinase medicine mitogen-activating p38 p38-MAPK pharmaceuticals protein research signaling therapies </dc:subject><content:encoded>&lt;a itemprop=&#034;url&#034; data-versiondate=&#034;2007-08-07T13:15:59+02:00&#034; href=&#034;http://circ.ahajournals.org/cgi/content/full/109/10/1196&#034; rel=&#034;nofollow&#034; class=&#034;description-link&#034;&gt;http://circ.ahajournals.org/cgi/content/full/109/10/1196&lt;/a&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/biomolecular"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/chemokines"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/chronic"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/cytokines"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/drugs"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/inflammation"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/inflammatory"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/inhibitors"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/interleukins"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/kinase"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/medicine"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/mitogen-activating"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/p38"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/p38-MAPK"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/pharmaceuticals"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/protein"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/research"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/signaling"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/therapies"/></rdf:Bag></taxo:topics></item><item rdf:about="http://findarticles.com/p/articles/mi_m1200/is_1_168/ai_n14842196/print"><title>Inflammation &amp; New Drug Research | Epoxyeicosatrienoic Acids (EETs) May be Protected with Enzyme Inhibitors (AUDA-BE, Compound 950)</title><description></description><link>http://findarticles.com/p/articles/mi_m1200/is_1_168/ai_n14842196/print</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-08-06T03:03:11+02:00</dc:date><dc:subject>AUDA-BE EETs acids chronic compound950 cytokines development drug enzymes epoxyeicosatrienoic inflammation inflammatory inhibitors interleukins pathophysiology research </dc:subject><content:encoded>&lt;a itemprop=&#034;url&#034; data-versiondate=&#034;2007-08-06T03:03:11+02:00&#034; href=&#034;http://findarticles.com/p/articles/mi_m1200/is_1_168/ai_n14842196/print&#034; rel=&#034;nofollow&#034; class=&#034;description-link&#034;&gt;http://findarticles.com/p/articles/mi_m1200/is_1_168/ai_n14842196/print&lt;/a&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/AUDA-BE"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/EETs"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/acids"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/chronic"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/compound950"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/cytokines"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/drug"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/enzymes"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/epoxyeicosatrienoic"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/inflammation"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/inflammatory"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/inhibitors"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/interleukins"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/pathophysiology"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/research"/></rdf:Bag></taxo:topics></item><item rdf:about="http://www.ciaomed.org/articles.cfm?articleID=543"><title>CIAOMed: Targeted Genetics Restructures to Advance Anti-TNF-Alpha Agent tgAAC94 for Inflammatory Arthritis</title><description>Clinical trial was just put on hold (7/27/2007) due to adverse effects in one trial participant...</description><link>http://www.ciaomed.org/articles.cfm?articleID=543</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-07-27T14:27:16+02:00</dc:date><dc:subject>agent anti-TNF-alpha arthritis clinical development drug genetics inflammatory rheumatology targeted tgAAC94 trials </dc:subject><content:encoded>&lt;span itemprop=&#034;description&#034;&gt;Clinical trial was just put on hold (7/27/2007) due to adverse effects in one trial participant...&lt;/span&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/agent"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/anti-TNF-alpha"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/arthritis"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/clinical"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/drug"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/genetics"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/inflammatory"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/rheumatology"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/targeted"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/tgAAC94"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/trials"/></rdf:Bag></taxo:topics></item><item rdf:about="http://www.altavista.com/web/results?itag=ody&amp;kgs=0&amp;kls=0&amp;q=atherosclerosis+p38+mitogen-activated+kinase+glaxo&amp;stq=10"><title>AltaVista Search: atherosclerosis p38 mitogen-activated kinase glaxo</title><description></description><link>http://www.altavista.com/web/results?itag=ody&amp;kgs=0&amp;kls=0&amp;q=atherosclerosis+p38+mitogen-activated+kinase+glaxo&amp;stq=10</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-07-27T13:29:51+02:00</dc:date><dc:subject>GSK MAPK atherosclerosis development drug glaxo glaxosmithkline inhibitors kinase mitogen-activated p38 </dc:subject><content:encoded>&lt;a itemprop=&#034;url&#034; data-versiondate=&#034;2007-07-27T13:29:51+02:00&#034; href=&#034;http://www.altavista.com/web/results?itag=ody&amp;amp;kgs=0&amp;amp;kls=0&amp;amp;q=atherosclerosis+p38+mitogen-activated+kinase+glaxo&amp;amp;stq=10&#034; rel=&#034;nofollow&#034; class=&#034;description-link&#034;&gt;http://www.altavista.com/web/results?itag=ody&amp;amp;kgs=0&amp;amp;kls=0&amp;amp;q=atherosclerosis+p38+mitogen-activated+kinase+glaxo&amp;amp;stq=10&lt;/a&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/GSK"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/MAPK"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/atherosclerosis"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/drug"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/glaxo"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/glaxosmithkline"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/inhibitors"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/kinase"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/mitogen-activated"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/p38"/></rdf:Bag></taxo:topics></item><item rdf:about="http://www.jimmunol.org/cgi/content/abstract/168/8/4070"><title>Anti-Inflammatory Effects of a p38 Mitogen-Activated Protein Kinase Inhibitor During Human Endotoxemia</title><description>The anti-inflammatory potential of an oral p38 MAPK inhibitor in humans in vivo suggests that p38 MAPK inhibitors may provide a new therapeutic option in the treatment of inflammatory diseases. Boehringer Ingelheim. 2002  Branger J, et al </description><link>http://www.jimmunol.org/cgi/content/abstract/168/8/4070</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-07-27T00:43:26+02:00</dc:date><dc:subject>boehringer cardiology cardiovascular cytokines development drug immunology inflammation inflammatory ingelheim inhibitors kinase mitogen-activated p38 protein </dc:subject><content:encoded>&lt;span itemprop=&#034;description&#034;&gt;The anti-inflammatory potential of an oral p38 MAPK inhibitor in humans in vivo suggests that p38 MAPK inhibitors may provide a new therapeutic option in the treatment of inflammatory diseases. Boehringer Ingelheim. 2002  Branger J, et al &lt;/span&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/boehringer"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/cardiology"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/cardiovascular"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/cytokines"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/drug"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/immunology"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/inflammation"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/inflammatory"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/ingelheim"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/inhibitors"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/kinase"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/mitogen-activated"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/p38"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/protein"/></rdf:Bag></taxo:topics></item><item rdf:about="http://jpet.aspetjournals.org/cgi/reprint/301/1/15.pdf"><title>Sustained Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Vascular Response to Injury</title><description>p38 MAPK inhibitors represent a novel therapeutic approach to the treatment of restenosis associated with coronary angioplasty.</description><link>http://jpet.aspetjournals.org/cgi/reprint/301/1/15.pdf</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-07-27T00:27:27+02:00</dc:date><dc:subject>2001 GSK MAPK cardiology cardiovascular cytokines development drug fibronectin glaxosmithkline inflammation inflammatory inhibitors injury kinase mitogen-activated neointima novel pharmacology protein remodeling vascular willette </dc:subject><content:encoded>&lt;span itemprop=&#034;description&#034;&gt;p38 MAPK inhibitors represent a novel therapeutic approach to the treatment of restenosis associated with coronary angioplasty.&lt;/span&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/2001"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/GSK"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/MAPK"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/cardiology"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/cardiovascular"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/cytokines"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/drug"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/fibronectin"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/glaxosmithkline"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/inflammation"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/inflammatory"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/inhibitors"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/injury"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/kinase"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/mitogen-activated"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/neointima"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/novel"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/pharmacology"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/protein"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/remodeling"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/vascular"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/willette"/></rdf:Bag></taxo:topics></item><item rdf:about="http://www.medicalnewstoday.com/articles/74585.php"><title>Nuvigil is FDA Approved =::= Cephalon Celebrates</title><description></description><link>http://www.medicalnewstoday.com/articles/74585.php</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-07-23T17:50:02+02:00</dc:date><dc:subject>ADD ADHD FDA adrafinil alertness ampakine approved armodafinil cephalon depression development drug eugeroic fatigue modafinil new wakefulness </dc:subject><content:encoded>&lt;a itemprop=&#034;url&#034; data-versiondate=&#034;2007-07-23T17:50:02+02:00&#034; href=&#034;http://www.medicalnewstoday.com/articles/74585.php&#034; rel=&#034;nofollow&#034; class=&#034;description-link&#034;&gt;http://www.medicalnewstoday.com/articles/74585.php&lt;/a&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/ADD"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/ADHD"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/FDA"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/adrafinil"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/alertness"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/ampakine"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/approved"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/armodafinil"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/cephalon"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/depression"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/drug"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/eugeroic"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/fatigue"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/modafinil"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/new"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/wakefulness"/></rdf:Bag></taxo:topics></item><item rdf:about="http://www.medicalnewstoday.com/articles/75745.php"><title>New Adult ADHD Drug Development</title><description></description><link>http://www.medicalnewstoday.com/articles/75745.php</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-07-20T02:52:22+02:00</dc:date><dc:subject>ADD ADHD development drug pharmaceuticals shire </dc:subject><content:encoded>&lt;a itemprop=&#034;url&#034; data-versiondate=&#034;2007-07-20T02:52:22+02:00&#034; href=&#034;http://www.medicalnewstoday.com/articles/75745.php&#034; rel=&#034;nofollow&#034; class=&#034;description-link&#034;&gt;http://www.medicalnewstoday.com/articles/75745.php&lt;/a&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/ADD"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/ADHD"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/drug"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/pharmaceuticals"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/shire"/></rdf:Bag></taxo:topics></item><item rdf:about="http://www.pharmaceutical-business-review.com/article_news.asp?guid=9A904653-FD9B-44B6-9699-AEBDDC782C1A"><title>Baxter Begins Trial of Stem Cells for Angiogenesis in Coronary Artery Disease =|= Pharmaceutical Business Review</title><description> commences trial of stem cells in coronary artery disease</description><link>http://www.pharmaceutical-business-review.com/article_news.asp?guid=9A904653-FD9B-44B6-9699-AEBDDC782C1A</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-07-15T16:33:43+02:00</dc:date><dc:subject>artery atherosclerosis baxter cardiology cardiovascular cells clinical clinical_trials coronary development disease drugs medicine occlusion pharma pharmaceuticals plaque progenitor stem stemcells syndrome trials </dc:subject><content:encoded>&lt;span itemprop=&#034;description&#034;&gt; commences trial of stem cells in coronary artery disease&lt;/span&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/artery"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/atherosclerosis"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/baxter"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/cardiology"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/cardiovascular"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/cells"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/clinical"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/clinical_trials"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/coronary"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/disease"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/drugs"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/medicine"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/occlusion"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/pharma"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/pharmaceuticals"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/plaque"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/progenitor"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/stem"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/stemcells"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/syndrome"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/trials"/></rdf:Bag></taxo:topics></item><item rdf:about="https://www.cmrinteract.com/clintrial/"><title>Association of the British Pharmaceutical Industry (ABPI) =|= Pharmaceutical Industry Clinical Trials Database</title><description></description><link>https://www.cmrinteract.com/clintrial/</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-07-08T05:54:21+02:00</dc:date><dc:subject>UK britain british clinical clinical_trials clinicaltrials databases development drug_development drugs pharma pharmaceutical pharmaceuticals registers registries search searchable trials </dc:subject><content:encoded>&lt;a itemprop=&#034;url&#034; data-versiondate=&#034;2007-07-08T05:54:21+02:00&#034; href=&#034;https://www.cmrinteract.com/clintrial/&#034; rel=&#034;nofollow&#034; class=&#034;description-link&#034;&gt;https://www.cmrinteract.com/clintrial/&lt;/a&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/UK"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/britain"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/british"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/clinical"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/clinical_trials"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/clinicaltrials"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/databases"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/drug_development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/drugs"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/pharma"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/pharmaceutical"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/pharmaceuticals"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/registers"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/registries"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/search"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/searchable"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/trials"/></rdf:Bag></taxo:topics></item><item rdf:about="http://newmeds.phrma.org/"><title>PhRMA =|= New Medicines in Development =|= Database</title><description></description><link>http://newmeds.phrma.org/</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-07-08T05:52:11+02:00</dc:date><dc:subject>PhRMA australia australian clinical clinical_trials clinicaltrials databases development drug_development drugs pharma pharmaceutical pharmaceuticals registers registries search searchable trials </dc:subject><content:encoded>&lt;a itemprop=&#034;url&#034; data-versiondate=&#034;2007-07-08T05:52:11+02:00&#034; href=&#034;http://newmeds.phrma.org/&#034; rel=&#034;nofollow&#034; class=&#034;description-link&#034;&gt;http://newmeds.phrma.org/&lt;/a&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/PhRMA"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/australia"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/australian"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/clinical"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/clinical_trials"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/clinicaltrials"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/databases"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/drug_development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/drugs"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/pharma"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/pharmaceutical"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/pharmaceuticals"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/registers"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/registries"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/search"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/searchable"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/trials"/></rdf:Bag></taxo:topics></item><item rdf:about="http://www.clinicaltrials.jp/user/cte_main.jsp"><title>Japan Pharmaceutical Information Center Register</title><description></description><link>http://www.clinicaltrials.jp/user/cte_main.jsp</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-07-08T05:48:34+02:00</dc:date><dc:subject>center clinical clinical_trials clinicaltrials databases development drug_development drugs information japan japanese pharma pharmaceutical pharmaceuticals registers registries search searchable trials </dc:subject><content:encoded>&lt;a itemprop=&#034;url&#034; data-versiondate=&#034;2007-07-08T05:48:34+02:00&#034; href=&#034;http://www.clinicaltrials.jp/user/cte_main.jsp&#034; rel=&#034;nofollow&#034; class=&#034;description-link&#034;&gt;http://www.clinicaltrials.jp/user/cte_main.jsp&lt;/a&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/center"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/clinical"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/clinical_trials"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/clinicaltrials"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/databases"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/drug_development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/drugs"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/information"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/japan"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/japanese"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/pharma"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/pharmaceutical"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/pharmaceuticals"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/registers"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/registries"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/search"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/searchable"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/trials"/></rdf:Bag></taxo:topics></item><item rdf:about="http://www.physorg.com/news102225930.html"><title>Vermont Psychiatrists Gifted an Average of $45,700 Each by Pharmaceutical Companies in 2006</title><description>Vermont officials said drug company payments to psychiatrists in the state averaged $45,692 EACH!, up from $20,835 in 2005; this doesn&#039;t include drug samples...</description><link>http://www.physorg.com/news102225930.html</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-06-28T10:01:51+02:00</dc:date><dc:subject>antipsychotics bigpharma companies development drug drugs free gifts marketing payments pharma pharmaceuticals psychiatrists samples vermont </dc:subject><content:encoded>&lt;span itemprop=&#034;description&#034;&gt;Vermont officials said drug company payments to psychiatrists in the state averaged $45,692 EACH!, up from $20,835 in 2005; this doesn&amp;#039;t include drug samples...&lt;/span&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/antipsychotics"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/bigpharma"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/companies"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/drug"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/drugs"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/free"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/gifts"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/marketing"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/payments"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/pharma"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/pharmaceuticals"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/psychiatrists"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/samples"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/vermont"/></rdf:Bag></taxo:topics></item><item rdf:about="http://www.km4dev.org/journal/index.php/km4dj"><title>Knowledge Management for Development Journal</title><description>An open access, peer-reviewed, community journal on knowledge management in development - for and by development practitioners and researchers.</description><link>http://www.km4dev.org/journal/index.php/km4dj</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-06-27T03:39:08+02:00</dc:date><dc:subject>KM development journals knowledge knowledge_management management </dc:subject><content:encoded>&lt;span itemprop=&#034;description&#034;&gt;An open access, peer-reviewed, community journal on knowledge management in development - for and by development practitioners and researchers.&lt;/span&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/KM"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/journals"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/knowledge"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/knowledge_management"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/management"/></rdf:Bag></taxo:topics></item><item rdf:about="http://www.davecheong.com/2007/06/15/waking-up-early-15-tips-that-work/"><title>Waking Up Early =|= 15 Tips That Work</title><description>Let me first start by saying that waking up early has made a huge difference in my life. I used to be the complete opposite - late sleeper and late riser. These days, I wake up at 5:30am everyday.</description><link>http://www.davecheong.com/2007/06/15/waking-up-early-15-tips-that-work/</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-06-18T06:30:46+02:00</dc:date><dc:subject>GTD accomplishments development early goals mornings personal productive productivity riser sleep success waking </dc:subject><content:encoded>&lt;span itemprop=&#034;description&#034;&gt;Let me first start by saying that waking up early has made a huge difference in my life. I used to be the complete opposite - late sleeper and late riser. These days, I wake up at 5:30am everyday.&lt;/span&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/GTD"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/accomplishments"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/early"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/goals"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/mornings"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/personal"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/productive"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/productivity"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/riser"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/sleep"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/success"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/waking"/></rdf:Bag></taxo:topics></item><item rdf:about="http://www.thepassiontest.com/Passion/home/index.cfm?"><title>Living a Life on Fire =|= Discovering Your Personal Secrets to a Passionate Life</title><description></description><link>http://www.thepassiontest.com/Passion/home/index.cfm?</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-06-18T05:38:09+02:00</dc:date><dc:subject>bliss careers coaching counseling development discovery fire life lifedev lifework living passion personal psychology psychosocial quizzes spirit spirituality tests wellbeing worklife worklives </dc:subject><content:encoded>&lt;a itemprop=&#034;url&#034; data-versiondate=&#034;2007-06-18T05:38:09+02:00&#034; href=&#034;http://www.thepassiontest.com/Passion/home/index.cfm?&#034; rel=&#034;nofollow&#034; class=&#034;description-link&#034;&gt;http://www.thepassiontest.com/Passion/home/index.cfm?&lt;/a&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/bliss"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/careers"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/coaching"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/counseling"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/discovery"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/fire"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/life"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/lifedev"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/lifework"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/living"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/passion"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/personal"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/psychology"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/psychosocial"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/quizzes"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/spirit"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/spirituality"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/tests"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/wellbeing"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/worklife"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/worklives"/></rdf:Bag></taxo:topics></item><item rdf:about="http://www.tutorialdash.com/"><title>Webmastering Tutorials</title><description>From TutorialDash.com</description><link>http://www.tutorialdash.com/</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-06-14T05:01:50+02:00</dc:date><dc:subject>CSS DHTML HTML XHTML XML advice creating creation design development guides howto lessons links mastering recommendations references resources sites tips tools tutorialdash tutorials web webdesign webdev webmaster website </dc:subject><content:encoded>&lt;span itemprop=&#034;description&#034;&gt;From TutorialDash.com&lt;/span&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/CSS"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/DHTML"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/HTML"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/XHTML"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/XML"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/advice"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/creating"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/creation"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/design"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/guides"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/howto"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/lessons"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/links"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/mastering"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/recommendations"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/references"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/resources"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/sites"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/tips"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/tools"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/tutorialdash"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/tutorials"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/web"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/webdesign"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/webdev"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/webmaster"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/website"/></rdf:Bag></taxo:topics></item><item rdf:about="http://www.sasklearning.gov.sk.ca/branches/institutions/rpl/docs/Level_1_RPL_Guide.pdf"><title>Facilitator’s Guide to Reflection and Portfolio Development</title><description></description><link>http://www.sasklearning.gov.sk.ca/branches/institutions/rpl/docs/Level_1_RPL_Guide.pdf</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-06-10T07:45:29+02:00</dc:date><dc:subject>career development facilitation facilitators groups leadership participatory portfolios </dc:subject><content:encoded>&lt;a itemprop=&#034;url&#034; data-versiondate=&#034;2007-06-10T07:45:29+02:00&#034; href=&#034;http://www.sasklearning.gov.sk.ca/branches/institutions/rpl/docs/Level_1_RPL_Guide.pdf&#034; rel=&#034;nofollow&#034; class=&#034;description-link&#034;&gt;http://www.sasklearning.gov.sk.ca/branches/institutions/rpl/docs/Level_1_RPL_Guide.pdf&lt;/a&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/career"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/facilitation"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/facilitators"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/groups"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/leadership"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/participatory"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/portfolios"/></rdf:Bag></taxo:topics></item><item rdf:about="http://www.xml.com/"><title>XML From the Inside Out =|=  XML Development  and Tools</title><description></description><link>http://www.xml.com/</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-06-03T16:52:24+02:00</dc:date><dc:subject>XML development howto portals programming resources tools </dc:subject><content:encoded>&lt;a itemprop=&#034;url&#034; data-versiondate=&#034;2007-06-03T16:52:24+02:00&#034; href=&#034;http://www.xml.com/&#034; rel=&#034;nofollow&#034; class=&#034;description-link&#034;&gt;http://www.xml.com/&lt;/a&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/XML"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/howto"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/portals"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/programming"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/resources"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/tools"/></rdf:Bag></taxo:topics></item><item rdf:about="http://www.anecdote.com.au/archives/sensemaking/"><title>Anecdote... ~:&#039;:~ ...Sensemaking Archive... ~:&#039;:~ ...Blog on Organisational Narrative &amp; Meaning-Making</title><description>Business narrative is a set of techniques based on the collection and interpretation of stories collected from a workplace. This technique is most effective when applied to seemingly intractable problems such as culture change, trust, innovation, leadersh</description><link>http://www.anecdote.com.au/archives/sensemaking/</link><dc:creator>avivagabriel</dc:creator><dc:date>2007-05-24T00:21:53+02:00</dc:date><dc:subject>CoPs ELSUA agents allegories anecdotal anecdote anomaly archetypal archetypes assets awareness beliefs brainstorming building business capital change circle circles coherence collaboration communities conflict congruence consciousness constructive corporate creativity culture design destructive development deviant experiential facilitating facilitators factors gladweel group harvesting heroes heuristics human humanizing identity information integrity intervention interviewing knowledge leading learning legends management mapping mavens mavericks mediators metaphors mindmapping mining myths narrative narratives negative networkings optimization organizational peace peacemaking people perspectives pioneering planning positive possibilities practice protagonists qualitative raising relational relationship resolution restructuring roles scapegoats self-actualization sensemaker sensemaking sharing social sociocultural sociology stories storytelling surveying systems thinking trust urban workshop </dc:subject><content:encoded>&lt;span itemprop=&#034;description&#034;&gt;Business narrative is a set of techniques based on the collection and interpretation of stories collected from a workplace. This technique is most effective when applied to seemingly intractable problems such as culture change, trust, innovation, leadersh&lt;/span&gt;</content:encoded><taxo:topics><rdf:Bag><rdf:li rdf:resource="https://www.bibsonomy.org/tag/CoPs"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/ELSUA"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/agents"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/allegories"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/anecdotal"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/anecdote"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/anomaly"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/archetypal"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/archetypes"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/assets"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/awareness"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/beliefs"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/brainstorming"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/building"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/business"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/capital"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/change"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/circle"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/circles"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/coherence"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/collaboration"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/communities"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/conflict"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/congruence"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/consciousness"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/constructive"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/corporate"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/creativity"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/culture"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/design"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/destructive"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/development"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/deviant"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/experiential"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/facilitating"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/facilitators"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/factors"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/gladweel"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/group"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/harvesting"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/heroes"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/heuristics"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/human"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/humanizing"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/identity"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/information"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/integrity"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/intervention"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/interviewing"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/knowledge"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/leading"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/learning"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/legends"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/management"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/mapping"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/mavens"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/mavericks"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/mediators"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/metaphors"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/mindmapping"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/mining"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/myths"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/narrative"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/narratives"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/negative"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/networkings"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/optimization"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/organizational"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/peace"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/peacemaking"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/people"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/perspectives"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/pioneering"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/planning"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/positive"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/possibilities"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/practice"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/protagonists"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/qualitative"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/raising"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/relational"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/relationship"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/resolution"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/restructuring"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/roles"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/scapegoats"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/self-actualization"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/sensemaker"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/sensemaking"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/sharing"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/social"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/sociocultural"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/sociology"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/stories"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/storytelling"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/surveying"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/systems"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/thinking"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/trust"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/urban"/><rdf:li rdf:resource="https://www.bibsonomy.org/tag/workshop"/></rdf:Bag></taxo:topics></item></rdf:RDF>